OvAge: an innovative, user-friendly digital methodology that quantifies ovarian reserve by integrating clinical, biochemical and 3D-sonographic data to help decision-making in all phases of woman life

Informazioni relative al progetto

Ovage

ID dell’accordo di sovvenzione: 781853

DOI

10.3030/781853

Progetto chiuso

Data della firma CE 31 Luglio 2017

Data di avvio 1 Agosto 2017

Data di completamento 31 Gennaio 2018

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

OVAGE SRL
Italy

Periodic Reporting for period 1 - Ovage (OvAge: an innovative, user-friendly digital methodology that quantifies ovarian reserve by integratingclinical, biochemical and 3D-sonographic data to help decision-making in all phases of woman life)

Periodo di rendicontazione: 2017-08-01 al 2018-01-31

Sintesi del contesto e degli obiettivi generali del progetto

Infertility is becoming a public health issue in Europe. In the EU, infertility affects approximately 25 million citizens . In worildwide, it is estimated that one out of six people experience some form of infertility during their reproductive lifespan. Europe is characterized by low fertility, postponed childbearing, increase in childlessness among younger generations. OvAge s.r.l. is a business start-up born from one of the best cutting-edge research of the University Magna Graecia of Catanzaro. Its mission is to improve women quality of life by bringing to the international market medical devices for the solution of gynaecological diseases. OvAge s.r.l. is the owner of a pioneering medical device-software able in quantifying women ovarian reserve (OR) by integrating clinical, biochemical and 3D- ultrasonographic data. This instrument, called OvAge®, is already developed as a patented mathematical algorithm. OvAge® combines complementary evaluations to give as a result explicitly the ovarian age of every woman, a ready-to-use information that is going to revolutionize the relationship of women with themselves, their life and with the Specialists in the field of Gynaecology

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

Ovage are planning to launch our product in the EU market initially through a web site. After SME instrument phase 1 conclusion, we aim to commercialize it in the rest of the EU market and in the rest of the world. Actually the Ovage's sell strategy contemplates a unique selling point into the web But, this is the best strategy?
The objective of the activities is to identify the best market strategy for Ovage.
The project plan was developed in 4 steps:
1. Recognize the characteristics of the market (Market segment identification)
2. Evaluate best process to keep a client's business (positioning strategy)
3. Define the Ovage’s commercial strategy
4. Investigate possible risks in our commercial strategy

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

At the end of the project Ovage knows:
- the right firm positioning
- the product and price strategy to be adopted
- the right price to transfer the rights of the patent

Ovage's logo